RPRX
WATCH Royalty Pharma plc · US
—
—
Prices as of close 2026-07-28
Cash-generating biotech royalty model offers defensive growth and catalyst-backed upside.
Buy signals
- ▸Morningstar highlights it as undervalued relative to covered biotech peers.
Related Biotech picks
AI-generated research for educational purposes only — not investment advice. Prices are end-of-day.